Crossmark

Gadoxetic acid-enhanced MRI in hepatocellular carcinoma: a comprehensive review of diagnostic, surveillance, and treatment response prediction and assessment

Crossref DOI link: https://doi.org/10.1007/s11604-025-01870-x

Published Online: 2025-09-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ozaki, Kumi https://orcid.org/0000-0002-1454-7512
Tanahashi, Yukichi

Goshima, Satoshi
License Information

Text and Data Mining valid from 2025-09-15

Version of Record valid from 2025-09-15
More Information

Article History

Received: 2 August 2025

Accepted: 3 September 2025

First Online: 15 September 2025

Declarations

:

: All the authors declare that they have no competing interests.

: The study was conducted in accordance with the ethical standards of the IRB and with the 1964 Helsinki Declaration and its later amendments.

Document is current

Any future updates will be listed below